Rubén Fernández-Santiago
Sobre mi
I earned a degree in Biology from the University of Oviedo in 2003 and a PhD in Neuroscience from the University of Tübingen in Germany in 2009 (Director: Prof. Thomas Gasser). I joined the lab of Prof. Eduardo Tolosa at IDIBAPS-Hospital Clínic de Barcelona in 2009 to investigate Parkinson disease (PD). I hold an ISCIII Miguel Servet position as independent PI and as Assoc. Prof. at the University of Barcelona. My research applies multi-disciplinary translational OMICS such as advanced epi-/genomics, transcriptomics, and phospho-proteomics to tackle the molecular mechanisms leading to neurodegeneration and to identify PD progression biomarkers, most especially at early prodromal stages.
Publicacions destacades
-
SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease
Autors:Referència: Movement Disorders 2019. -
Whole-genome DNA hyper-methylation in iPSC-derived dopaminergic neurons from Parkinson's disease patients
Autors:Referència: Clinical Epigenetics 2019. -
MicroRNA alterations in iPSC-derived dopaminergic neurons from Parkinson disease patients
Autors:Referència: Neurobiology Of Aging 2018. -
α-synuclein (SNCA) but not dynamin 3 (DNM3) influences age at onset of leucine-rich repeat kinase 2 (LRRK2) Parkinson's disease in Spain
Autors:Referència: Movement Disorders 2018. -
ABSENCE OF LRRK2 MUTATIONS IN A COHORT OF PATIENTS WITH IDIOPATHIC REM SLEEP BEHAVIOR DISORDER
Autors:Referència: Neurology 2016. -
The MC1R melanoma risk variant p.R160W is associated with Parkinson disease.
Autors:Referència: Annals Of Neurology 2015. -
MicroRNA Association with Synucleinopathy Conversion in Rapid Eye Movement Behavior Disorder
Autors:Referència: Annals Of Neurology 2015.
Projectes destacats
-
‘Phospho-proteome analysis of PBMCs in LRRK2 mutation carriers: expansion and validation of findings of the Barcelona LRRK2 Biorepository’ / Parkinson’s Pathway Biomarkers Fall 2020
Investigador/a principal: Ruben Fernandez SantiagoFinançador: The Michael J Fox Foundation for Parkinson´s Research (MJFF) (Programa financiador competitivo)Codi: MJFF-000858Durada: 28/02/2021 - 28/02/2023 -
‘Tackling the epigenetic regulation of a-synuclein in Parkinson disease’ / ISCIII AES-20 Proyectos de Investigación en Salud (FIS)
Investigador/a principal: Ruben Fernandez SantiagoFinançador: Instituto de Salud Carlos III (ISCIII) (Programa financiador competitivo)Codi: PI20/00659Durada: 01/01/2021 - 31/12/2023 -
'The beginnings of Parkinson Disease: a study of early disease mechanisms in a humanized in-vitro model'
Investigador/a principal: Rubén Fernández-SantiagoFinançador: MINECO-AEI (Agencia Estatal de Investigación) (Sede o evento); JIN - Jóvenes Investigadores MINECO (Programa financiador competitivo)Codi: SAF2015-73508-JINDurada: 01/01/2016 - 01/01/2019 -
‘MicroRNAs as biomarkers of the prodromal stage of Parkinson disease’
Investigador/a principal: Mario Ezquerra, Ruben Fernandez SantiagoFinançador: The Michael J Fox Foundation for Parkinson´s Research (MJFF) (Sede o evento); Improve biomarkers and clinical outcome measures (Programa financiador competitivo)Codi: 11159Durada: 01/01/2016 - 01/01/2018 -
‘Gene-gene interaction analysis of the mTOR pathway in L-DOPA induced dyskinesia’
Investigador/a principal: Mario Ezquerra Trabalón, Ruben Fernandez SantiagoFinançador: The Michael J Fox Foundation for Parkinson Research (MJFF) (Sede o evento); Dyskinesia Challenge (Programa financiador competitivo)Codi: MJFF_DYSK_2014Durada: 01/01/2014 - 01/01/2016